Immunisation Coalition: 25th Annual Scientific Meeting

Immunisation Coalition will hold its 25 Annual Scientific Meeting from 4 to 5 February 2024.

The meeting will be held in Melbourne and online, and will be chaired by A/Prof Lou Irving from the Royal Melbourne Hospital.

Find out more and register on the Immunisation Coalition's Annual Scientific Meeting event page.


MMWR: Progress in Immunization Safety Monitoring

A recent report shows that national AEFI (adverse event following immunisation) surveillance systems increasingly support the timely sharing of immunisation safety data, including individual case-based reports. When shared globally, individual case safety reports contribute to the description of trends and regional characteristics of AEFIs. 

But work is still needed to strengthen global vaccine safety monitoring, and to promote public confidence in national vaccine programs. 

MMWR: Progress in Immunization Safety Monitoring


New publication: Analyzing an immunization resource website

Researchers from SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) recently published an article in ‘Vaccine’, analysing user browsing trends on the MVEC website. 

Over a four-year period from 2019 to 2022, there was specific interest in vaccine-related topics corresponding with key vaccine topics like COVID-19 vaccine administration techniques and adverse events following immunisation. 

Vaccine: Analyzing an immunization resource website: User browsing trends


CDIC 2024: Call for abstracts

Communicable Diseases & Immunisation Conference (CDIC) 2024 will be held from 11 to 13 June 2024 in Brisbane. The CDIC is now accepting abstract submissions for presentations, until Friday 23 February 2024. 

Head to the Call for abstracts page on the CDIC website for more information about the conference topics and abstract requirements. 

The theme of the conference is “Protecting communities: Empowering health through disease control and immunisation”.


The importance of cold chain procedures over the holiday period

Breaches in the cold chain can result in reduced vaccine potency. Immunisation clinics closing for the holiday period are encouraged to perform a vaccine self-storage audit and review their vaccine management protocols. These steps can prevent the occurrence of a cold chain breach and limit the need for wasting vaccines.

After the break, it is important to review the data logger reports to identify whether any cold chain breaches have occurred. This ensures that any affected vaccines are not inadvertently administered, which could lead to an inadequate immune response and result in poor protection against disease.

For more information, visit the MVEC:冷链 reference page which includes a helpful animation that explains the cold chain journey.


Updated immunisation reference page: COVID‑19

We have updated our COVID-19 reference page with up-to-date guidance on currently available COVID-19 vaccines, across age groups.

The newly updated page includes recommendations on the use of the new monovalent XBB.1.5 vaccines and answers to commonly asked questions relating to the new vaccines as well as other COVID-19 vaccine-related queries. 

MVEC:COVID-19


Updated immunisation reference page: Typhoid

We have recently reviewed our typhoid reference page.

Typhoid and paratyphoid fever are collectively known as enteric fever. Caused by bacterial infections with Salmonella enterica subspecies, typhoid and paratyphoid fever often present with prolonged fever and fatigue, headaches, enlargement of the spleen, abdominal symptoms, bacterial blood infection.

Newly reviewed immunisation reference – MVEC: Typhoid


更新免疫参考页:带状疱疹(带状疱疹)

We have recently updated our zoster (also known as shingles) reference page.

Zoster is the reactivation of the varicella zoster virus (VZV) in people who have previously had varicella (chickenpox) infection. Zoster presents with a painful blistering rash. The most common complication of zoster is post-herpetic neuralgia.

In response to queries that have arisen since the new national Shingrix program commenced, the updated page provides more information about:

  • vaccine side effects 
  • special risk group eligibility for people with blood cancers 
  • pre-vaccination screening for Shingrix. 

MVEC:带状疱疹(带状疱疹)


Updated immunisation reference page: Tetanus

We have recently updated our tetanus reference page.

Tetanus is caused when exotoxins from the bacteria Clostridium Tetani enter the bloodstream and act on the central nervous system. Symptoms include muscle rigidity and painful spasms.

The new reference page includes new details on tetanus epidemiology, and detailed guidance on tetanus vaccination and the appropriate tetanus-prevention management of tetanus-prone wounds.

MVEC: Tetanus


GAVI: HPV vaccine roll-out in Nigeria

In late October, Nigeria began its public roll-out of the HPV vaccine.

After initial scepticism over the vaccine, community leaders campaigned to ensure the vaccine reaches all girls in the eligible age bracket.

Gavi reports, in great detail, on how the campaigners tackled misinformation and educated community member. Read more 这里.


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。